Literature DB >> 32996356

Public Health Interventions with Harms and Benefits: A Graphical Framework for Evaluating Tradeoffs.

Allison L Pitt1, Jeremy D Goldhaber-Fiebert2, Margaret L Brandeau1.   

Abstract

BACKGROUND: Evaluations of public health interventions typically report benefits and harms aggregated over the population. However, benefits and harms are not always evenly distributed. Examining disaggregated outcomes enables decision makers to consider health benefits and harms accruing to both intended intervention recipients and others in the population.
METHODS: We provide a graphical framework for categorizing and comparing public health interventions that examines the distribution of benefit and harm between and within population subgroups for a single intervention and compares distributions of harm and benefit for multiple interventions. We demonstrate the framework through a case study of a hypothetical increase in the price of meat (5%, 10%, 25%, or 50%) that, via elasticity of demand, reduces consumption and consequently reduces body mass index. We examine how inequalities in benefits and harms (measured by quality-adjusted life-years) are distributed across a population of white and black males and females.
RESULTS: A 50% meat price increase would yield the greatest net benefit to the population. However, because of reduced consumption among low-weight individuals, black males would bear disproportionate harm relative to the benefit they receive. With increasing meat price, the distribution of harm relative to benefit becomes less "internal" to those receiving benefit and more "distributed" to those not receiving commensurate benefit. When we segment the population by sex only, this result does not hold.
CONCLUSIONS: Disaggregating harms and benefits to understand their differential impact on subgroups can strongly affect which decision alternative is deemed optimal, as can the approach to segmenting the population. Our framework provides a useful tool for illuminating key tradeoffs relevant to harm-averse decision makers and those concerned with both equity and efficiency.

Entities:  

Keywords:  distributional effects; harm aversion; health technology assessment; multicriteria decision analysis

Mesh:

Year:  2020        PMID: 32996356      PMCID: PMC8056742          DOI: 10.1177/0272989X20960458

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  33 in total

1.  The measurement of individual utility and social welfare.

Authors:  P Dolan
Journal:  J Health Econ       Date:  1998-01       Impact factor: 3.883

2.  Good evidence begets good policy: or so it should be.

Authors:  Brian S Custer
Journal:  Transfusion       Date:  2012-03       Impact factor: 3.157

3.  QALYs and the equity-efficiency trade-off.

Authors:  A Wagstaff
Journal:  J Health Econ       Date:  1991-05       Impact factor: 3.883

4.  Social capital, income inequality, and self-rated health in 45 countries.

Authors:  Carol Mansyur; Benjamin C Amick; Ronald B Harrist; Luisa Franzini
Journal:  Soc Sci Med       Date:  2007-10-29       Impact factor: 4.634

Review 5.  A scoping review of unintended harm associated with public health interventions: towards a typology and an understanding of underlying factors.

Authors:  L K Allen-Scott; J M Hatfield; L McIntyre
Journal:  Int J Public Health       Date:  2014-01-01       Impact factor: 3.380

6.  Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis.

Authors:  Caroline Jehu-Appiah; Rob Baltussen; Charles Acquah; Moses Aikins; Salassi Amah d'Almeida; William K Bosu; Xander Koolman; Jeremy Lauer; Dan Osei; Sam Adjei
Journal:  Value Health       Date:  2008-12       Impact factor: 5.725

Review 7.  Intergenerational equity: an exploration of the 'fair innings' argument.

Authors:  A Williams
Journal:  Health Econ       Date:  1997 Mar-Apr       Impact factor: 3.046

8.  Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.

Authors:  Praveen Thokala; Nancy Devlin; Kevin Marsh; Rob Baltussen; Meindert Boysen; Zoltan Kalo; Thomas Longrenn; Filip Mussen; Stuart Peacock; John Watkins; Maarten Ijzerman
Journal:  Value Health       Date:  2016-01-08       Impact factor: 5.725

9.  Efficiency, equity, and budgetary policies: informing decisions using mathematical programming.

Authors:  David M Epstein; Zaid Chalabi; Karl Claxton; Mark Sculpher
Journal:  Med Decis Making       Date:  2007 Mar-Apr       Impact factor: 2.583

10.  Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.

Authors:  Aris Angelis; Panos Kanavos
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

View more
  1 in total

1.  Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.

Authors:  Thomas Ward; Ruben E Mujica-Mota; Anne E Spencer; Antonieta Medina-Lara
Journal:  Pharmacoeconomics       Date:  2021-10-29       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.